Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J Sebo

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
Urology|September 19, 2006
Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomyBrant A Inman, David S DiMarco, Jeffrey M Slezak, et al.
Urologic Oncology|December 25, 2003
Multivariate models to predict clinically important outcomes at prostatectomy for patients with organ-confined disease and needle biopsy Gleason scores of 6 or lessDavid S DiMarco, Michael L Blute, Horst Zincke, et al.
American Journal of Clinical Pathology|September 17, 2008
Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancerBenjamin R Kipp, Harmony L Tyner, Michael B Campion, et al.
The American Journal of Surgical Pathology|March 27, 2002
Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancerThomas J Sebo, John C Cheville, Darren L Riehle, et al.
The Journal of Clinical Endocrinology and Metabolism|August 9, 2007
Serum thyroglobulin, high-resolution ultrasound, and lymph node thyroglobulin in diagnosis of differentiated thyroid carcinoma nodal metastasesChristine L H Snozek, Eugene P Chambers, Carl C Reading, et al.
Human Pathology|November 11, 2003
Dedifferentiation in low-grade mucoepidermoid carcinoma of the parotid glandToshitaka Nagao, Thomas A Gaffey, Paul A Kay, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 28, 2005
RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumorsNobuki Nakamura, J Aidan Carney, Long Jin, et al.
Cancer|September 24, 2004
Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvementIgor Frank, John C Cheville, Michael L Blute, et al.
The American Journal of Surgical Pathology|May 17, 2011
Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfallsGladell P Paner, Jesse K McKenney, Güliz A Barkan, et al.
Mayo Clinic Proceedings|February 4, 2014
Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo modelMatthew K Tollefson, R Jeffrey Karnes, Eugene D Kwon, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Urology|September 19, 2006
Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomyBrant A Inman, David S DiMarco, Jeffrey M Slezak, et al.
Urologic Oncology|December 25, 2003
Multivariate models to predict clinically important outcomes at prostatectomy for patients with organ-confined disease and needle biopsy Gleason scores of 6 or lessDavid S DiMarco, Michael L Blute, Horst Zincke, et al.
American Journal of Clinical Pathology|September 17, 2008
Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancerBenjamin R Kipp, Harmony L Tyner, Michael B Campion, et al.
The American Journal of Surgical Pathology|March 27, 2002
Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancerThomas J Sebo, John C Cheville, Darren L Riehle, et al.
The Journal of Clinical Endocrinology and Metabolism|August 9, 2007
Serum thyroglobulin, high-resolution ultrasound, and lymph node thyroglobulin in diagnosis of differentiated thyroid carcinoma nodal metastasesChristine L H Snozek, Eugene P Chambers, Carl C Reading, et al.
Human Pathology|November 11, 2003
Dedifferentiation in low-grade mucoepidermoid carcinoma of the parotid glandToshitaka Nagao, Thomas A Gaffey, Paul A Kay, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 28, 2005
RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumorsNobuki Nakamura, J Aidan Carney, Long Jin, et al.
Cancer|September 24, 2004
Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvementIgor Frank, John C Cheville, Michael L Blute, et al.
The American Journal of Surgical Pathology|May 17, 2011
Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfallsGladell P Paner, Jesse K McKenney, Güliz A Barkan, et al.
Mayo Clinic Proceedings|February 4, 2014
Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo modelMatthew K Tollefson, R Jeffrey Karnes, Eugene D Kwon, et al.
Pageof 13